Beta Drugs Limited reported earnings results for the half year ended September 30, 2021. For the half year, the company reported sales was INR 880.96 million compared to INR 513.8 million a year ago. Revenue was INR 885.5 million compared to INR 516.39 million a year ago. Net income was INR 117.51 million compared to INR 51.81 million a year ago. Basic earnings per share from continuing operations was INR 12.22 compared to INR 5.39 a year ago. Diluted earnings per share from continuing operations was INR 12.22 compared to INR 5.39 a year ago.